vs
美盛公司（MOS）与TENET HEALTHCARE CORP（THC）财务数据对比。点击上方公司名可切换其他公司
TENET HEALTHCARE CORP的季度营收约是美盛公司的1.9倍（$5.5B vs $3.0B），TENET HEALTHCARE CORP净利率更高（11.7% vs -17.5%，领先29.1%），TENET HEALTHCARE CORP同比增速更快（9.0% vs 5.6%），TENET HEALTHCARE CORP自由现金流更多（$367.0M vs $-405.7M），过去两年美盛公司的营收复合增速更高（5.3% vs 1.5%）
美盛公司（The Mosaic Company）是总部位于美国佛罗里达州坦帕的化工企业，主营磷矿、钾矿开采及尿素采集，依托多元国际分销网络和旗下肥料业务板块生产销售农用肥料，是美国规模最大的钾肥、磷肥生产商。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业，旗下拥有USPI等多个品牌、子公司、合资企业及合作主体，运营65家医院及超过450个医疗设施，还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
MOS vs THC — 直观对比
营收规模更大
THC
是对方的1.9倍
$3.0B
营收增速更快
THC
高出3.4%
5.6%
净利率更高
THC
高出29.1%
-17.5%
自由现金流更多
THC
多$772.7M
$-405.7M
两年增速更快
MOS
近两年复合增速
1.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.0B | $5.5B |
| 净利润 | $-519.5M | $644.0M |
| 毛利率 | 11.5% | — |
| 营业利润率 | -3.4% | 15.4% |
| 净利率 | -17.5% | 11.7% |
| 营收同比 | 5.6% | 9.0% |
| 净利润同比 | -407.4% | 12.6% |
| 每股收益（稀释后） | $-1.63 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MOSTHC
| Q4 25 | $3.0B | $5.5B | ||
| Q3 25 | $3.5B | $5.3B | ||
| Q2 25 | $3.0B | $5.3B | ||
| Q1 25 | $2.6B | $5.2B | ||
| Q4 24 | $2.8B | $5.1B | ||
| Q3 24 | $2.8B | $5.1B | ||
| Q2 24 | $2.8B | $5.1B | ||
| Q1 24 | $2.7B | $5.4B |
净利润MOSTHC
| Q4 25 | $-519.5M | $644.0M | ||
| Q3 25 | $411.4M | $579.0M | ||
| Q2 25 | $410.7M | $522.0M | ||
| Q1 25 | $238.1M | $622.0M | ||
| Q4 24 | $169.0M | $572.0M | ||
| Q3 24 | $122.2M | $681.0M | ||
| Q2 24 | $-161.5M | $477.0M | ||
| Q1 24 | $45.2M | $2.3B |
毛利率MOSTHC
| Q4 25 | 11.5% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 17.3% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 14.9% | — |
营业利润率MOSTHC
| Q4 25 | -3.4% | 15.4% | ||
| Q3 25 | 9.8% | 16.8% | ||
| Q2 25 | 8.1% | 15.6% | ||
| Q1 25 | 12.9% | 18.1% | ||
| Q4 24 | 3.5% | 16.2% | ||
| Q3 24 | 4.1% | 21.3% | ||
| Q2 24 | 8.3% | 14.9% | ||
| Q1 24 | 6.5% | 61.2% |
净利率MOSTHC
| Q4 25 | -17.5% | 11.7% | ||
| Q3 25 | 11.9% | 10.9% | ||
| Q2 25 | 13.7% | 9.9% | ||
| Q1 25 | 9.1% | 11.9% | ||
| Q4 24 | 6.0% | 11.3% | ||
| Q3 24 | 4.3% | 13.3% | ||
| Q2 24 | -5.7% | 9.3% | ||
| Q1 24 | 1.7% | 43.5% |
每股收益（稀释后）MOSTHC
| Q4 25 | $-1.63 | $4.22 | ||
| Q3 25 | $1.29 | $3.86 | ||
| Q2 25 | $1.29 | $3.14 | ||
| Q1 25 | $0.75 | $4.27 | ||
| Q4 24 | $0.53 | $3.79 | ||
| Q3 24 | $0.38 | $4.89 | ||
| Q2 24 | $-0.50 | $2.64 | ||
| Q1 24 | $0.14 | $21.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $276.6M | $2.9B |
| 总债务越低越好 | $4.3B | $13.1B |
| 股东权益账面价值 | $12.1B | $4.2B |
| 总资产 | $24.5B | $29.7B |
| 负债/权益比越低杠杆越低 | 0.35× | 3.10× |
8季度趋势，按日历期对齐
现金及短期投资MOSTHC
| Q4 25 | $276.6M | $2.9B | ||
| Q3 25 | $153.3M | $3.0B | ||
| Q2 25 | $286.2M | $2.6B | ||
| Q1 25 | $259.2M | $3.0B | ||
| Q4 24 | $272.8M | $3.0B | ||
| Q3 24 | $301.6M | $4.1B | ||
| Q2 24 | $322.0M | $2.9B | ||
| Q1 24 | $336.7M | $2.5B |
总债务MOSTHC
| Q4 25 | $4.3B | $13.1B | ||
| Q3 25 | $3.4B | $13.1B | ||
| Q2 25 | $3.3B | $13.1B | ||
| Q1 25 | $3.3B | $13.1B | ||
| Q4 24 | $3.3B | $13.1B | ||
| Q3 24 | $3.2B | $12.8B | ||
| Q2 24 | $3.2B | $12.8B | ||
| Q1 24 | $3.2B | $12.8B |
股东权益MOSTHC
| Q4 25 | $12.1B | $4.2B | ||
| Q3 25 | $12.8B | $4.0B | ||
| Q2 25 | $12.4B | $3.7B | ||
| Q1 25 | $11.8B | $4.2B | ||
| Q4 24 | $11.5B | $4.2B | ||
| Q3 24 | $11.8B | $3.8B | ||
| Q2 24 | $11.7B | $3.5B | ||
| Q1 24 | $12.0B | $3.5B |
总资产MOSTHC
| Q4 25 | $24.5B | $29.7B | ||
| Q3 25 | $24.7B | $29.4B | ||
| Q2 25 | $24.3B | $28.7B | ||
| Q1 25 | $23.2B | $29.2B | ||
| Q4 24 | $22.9B | $28.9B | ||
| Q3 24 | $23.3B | $29.4B | ||
| Q2 24 | $22.6B | $29.3B | ||
| Q1 24 | $22.9B | $28.9B |
负债/权益比MOSTHC
| Q4 25 | 0.35× | 3.10× | ||
| Q3 25 | 0.26× | 3.26× | ||
| Q2 25 | 0.27× | 3.49× | ||
| Q1 25 | 0.28× | 3.13× | ||
| Q4 24 | 0.29× | 3.14× | ||
| Q3 24 | 0.27× | 3.33× | ||
| Q2 24 | 0.27× | 3.67× | ||
| Q1 24 | 0.27× | 3.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-56.1M | $731.0M |
| 自由现金流经营现金流 - 资本支出 | $-405.7M | $367.0M |
| 自由现金流率自由现金流/营收 | -13.6% | 6.6% |
| 资本支出强度资本支出/营收 | 11.8% | 6.6% |
| 现金转化率经营现金流/净利润 | — | 1.14× |
| 过去12个月自由现金流最近4个季度 | $-534.6M | $2.5B |
8季度趋势，按日历期对齐
经营现金流MOSTHC
| Q4 25 | $-56.1M | $731.0M | ||
| Q3 25 | $228.5M | $1.1B | ||
| Q2 25 | $609.5M | $936.0M | ||
| Q1 25 | $42.9M | $815.0M | ||
| Q4 24 | $219.3M | $-331.0M | ||
| Q3 24 | $312.9M | $1.0B | ||
| Q2 24 | $847.0M | $747.0M | ||
| Q1 24 | $-80.0M | $586.0M |
自由现金流MOSTHC
| Q4 25 | $-405.7M | $367.0M | ||
| Q3 25 | $-135.9M | $778.0M | ||
| Q2 25 | $304.9M | $743.0M | ||
| Q1 25 | $-297.9M | $642.0M | ||
| Q4 24 | $-74.8M | $-661.0M | ||
| Q3 24 | $72.1M | $829.0M | ||
| Q2 24 | $513.1M | $602.0M | ||
| Q1 24 | $-463.0M | $346.0M |
自由现金流率MOSTHC
| Q4 25 | -13.6% | 6.6% | ||
| Q3 25 | -3.9% | 14.7% | ||
| Q2 25 | 10.1% | 14.1% | ||
| Q1 25 | -11.4% | 12.3% | ||
| Q4 24 | -2.7% | -13.0% | ||
| Q3 24 | 2.6% | 16.2% | ||
| Q2 24 | 18.2% | 11.8% | ||
| Q1 24 | -17.3% | 6.4% |
资本支出强度MOSTHC
| Q4 25 | 11.8% | 6.6% | ||
| Q3 25 | 10.6% | 5.3% | ||
| Q2 25 | 10.1% | 3.7% | ||
| Q1 25 | 13.0% | 3.3% | ||
| Q4 24 | 10.4% | 6.5% | ||
| Q3 24 | 8.6% | 4.2% | ||
| Q2 24 | 11.9% | 2.8% | ||
| Q1 24 | 14.3% | 4.5% |
现金转化率MOSTHC
| Q4 25 | — | 1.14× | ||
| Q3 25 | 0.56× | 1.83× | ||
| Q2 25 | 1.48× | 1.79× | ||
| Q1 25 | 0.18× | 1.31× | ||
| Q4 24 | 1.30× | -0.58× | ||
| Q3 24 | 2.56× | 1.53× | ||
| Q2 24 | — | 1.57× | ||
| Q1 24 | -1.77× | 0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MOS
暂无分部数据
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |
